Development of a Novel Yeast Cell-Based System for Studying the Aggregation of Alzheimer’s Disease-Associated Aβ Peptides in vivo

Publisher： Karger

E-ISSN： 1660-2862|4|2-3|136-147

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.4, Iss.2-3, 2007-06, pp. : 136-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of the Performance of Novel Aβ Isoforms as Theragnostic Markers in Alzheimer’s Disease: From the Cell to the Patient

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-02 ,pp. : 138-140

Karger

Access to resources Recommend Favorite

Aβ Immunotherapy: Lessons Learned for Potential Treatment of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 5, 2006-02 ,pp. : 255-260

Karger

Access to resources Recommend Favorite

Intraneuronal Aβ Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 10, Iss. 1-4, 2012-01 ,pp. : 56-59

Karger

Access to resources Recommend Favorite

Passive Immunization of the Aβ42(43) C-Terminal-Specific Antibody BC05 in a Mouse Model of Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 2, Iss. 1, 2005-08 ,pp. : 36-43

Karger

Access to resources Recommend Favorite

Oligomerization Partially Explains the Lowering of Aβ42 in Alzheimer’s Disease Cerebrospinal Fluid

By  

Neurodegenerative Diseases, Vol. 6, Iss. 4, 2009-06 ,pp. : 139-147

Karger

Access to resources Recommend Favorite